Pediatric Allergy Asthma News

SAN DIEGO — Aquestive Therapeutics’ Anaphylm AQST-109 epinephrine sublingual film demonstrated durability despite testing in extreme temperatures and other environmental conditions, according to a pair of posters presented here.

SAN DIEGO — OB/GYNs reported feeling more comfortable performing penicillin allergy delabeling among pregnant women compared with allergists, according to a presentation here.

The FDA approved Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of multiple conditions including asthma and food allergy, according to an agency press release.

The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 years and older, according to a press release from ARS Pharma.

SAN DIEGO — Patients with multiple food allergies introduced allergens into their diets after using omalizumab, researchers reported at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.

SAN DIEGO — Patients with three different food allergies who used omalizumab experienced better outcomes than patients who used multi-food oral immunotherapy, driven by lower rates of adverse events, according to an abstract presented here.

SAN DIEGO — Following use of race-neutral lung function equations, African American and Latino pediatric patients with asthma had reductions in FEV1 and FVC while white patients with asthma had increases, according to a presentation here.

SAN DIEGO — Food allergy anxiety is a unique subtype of anxiety that merits specific assessment and tailored interventions, according to an abstract presented here.

SAN DIEGO — Infants who did not exclusively feed on colostrum during their first 3 days of life were more likely to develop egg or peanut allergy, according to an abstract presented here.